IE
AKTX

Israel Englander’s Akari Therapeutics AKTX Stock Holding History

Israel Englander’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-168
Closed -$22.8K – 6071
2023
Q2 		$22.8K Sell
168
-158
-48% -$22.8K ﹤0.01% 5609
2023
Q1 		$47K Buy
326
+257
+372% +$81K ﹤0.01% 5641
2022
Q4 		$27K Buy
69
+22
+47% +$9.1K ﹤0.01% 5966
2022
Q3 		$24K Buy
47
+29
+161% +$23.9K ﹤0.01% 6412
2022
Q2 		$14K Buy
+18
New +$16K ﹤0.01% 6577
2021
Q4 		– Sell
-19
Closed -$25K – 6716
2021
Q3 		$25K Buy
+19
New +$25.8K ﹤0.01% 6646
2020
Q3 		– Sell
-34
Closed -$59K – 4398
2020
Q2 		$59K Buy
+34
New +$51.8K ﹤0.01% 4037
2019
Q1 		– Sell
-34
Closed -$43K – 3944
2018
Q4 		$43K Hold
34
– – ﹤0.01% 3625
2018
Q3 		$70K Sell
34
-10
-23% -$16.1K ﹤0.01% 3772
2018
Q2 		$69K Sell
44
-169
-79% -$265K ﹤0.01% 3683
2018
Q1 		$311K Sell
213
-112
-34% -$242K ﹤0.01% 3200
2017
Q4 		$1.13M Buy
325
+181
+126% +$698K ﹤0.01% 2632
2017
Q3 		$709K Sell
144
-124
-46% -$465K ﹤0.01% 2682
2017
Q2 		$987K Buy
+268
New +$2.12M ﹤0.01% 2451
2016
Q1 		– Sell
-64
Closed -$743K – 3227
2015
Q4 		$743K Sell
64
-13
-17% -$193K ﹤0.01% 2448
2015
Q3 		$1.49M Buy
+77
New +$911K ﹤0.01% 2086

Other funds holding AKTX

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
OFW
Omnia Family Wealth Aventura, Florida $373M AUM 25.3% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $673M AUM 55.24% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return

Israel Englander's AKTX Position: Q3 2023 in Review

Israel Englander sold out of Akari Therapeutics (AKTX) in Q3 2023, closing a stake of 168 shares — an estimated $22.8K sold.

Israel Englander first reported a position in AKTX in Q3 2015 and held it in 16 quarters. The position peaked at $1.49M in Q3 2015. 7 funds tracked by Wall St. Rank hold AKTX as of Q3 2023.

  • Israel Englander reported no remaining Akari Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Israel Englander sold 168 Akari Therapeutics shares in Q3 2023, an estimated $22.8K.
  • Israel Englander first reported a position in Akari Therapeutics in Q3 2015 and held it in 16 quarters.
  • Israel Englander's Akari Therapeutics position peaked at $1.49M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Akari Therapeutics as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.